2019 Bioelectronic Medicine Forum

Millennium Broadway, New York, NY, April 4, 2019

Tentative Agenda

8:00-8:30

Registration and Coffee

8:30-8:45

Overview of the Bioelectronic Medicine Industry

James Cavuoto, Editor and Publisher, Neurotech Reports
Neurotech Business Report Editor James Cavuoto presents an overview of the bioelectronic medicine industry, including key players, technological roots, and market projections.
8:45-9:15

Keynote Address

Sue Siegel, Chief Innovation Officer, CEO, GE Ventures
This keynote session features observations from a major investor and innovator in the medical device industry.
9:15-10:00

Investment in Bioelectronic Medicine

Imran Eba, Partner, Action Potential Venture Capital, Moderator
Evan Norton, Divisional Vice President, Abbott Ventures
Jeff Erb, Senior Director, Business Development, Medtronic
Eric Van Gieson, Ph.D., Program Manager, DARPA
In this session, investment professionals active in the life sciences industry will offer their views on the investment climate for bioelectronic medicine.
10:00-10:15

Refreshment Break

10:15-11:15

Entrepreneur Panel I

James Cavuoto, Editor and Publisher, Neurotech Reports, Moderator
Daniel Powell, CEO, Spark Biomedical
Jennifer Ernst, CEO, Tivic Health
Attila Borbath, Co-founder and CEO, Synergia Medical
Don Deyo, CEO, FemPulse LLC
Presentations from executives of emerging bioelectronic medicine firms.
11:15-12:00

New Devices Up Our Sleeve: Neuromodulation Gets Personal

Jennifer French, Senior Editor, Neurotech Reports, Moderator
Marom Bikson, Ph.D., Director, Neural Engineering Laboratory, CCNY
Shai Gozani, M.D., Ph.D., President and CEO, Neurometrix Inc.
Samuel Hamner, Ph.D., Director of Technology and Product Marketing, Cala Health
Bioelectronic medicine now incorporates new wearable diagnostic, therapeutic, and software devices and vendors are exploring new distribution channels and revenue models. In this session, we'll discuss trends in digital health, direct-to-consumer marketing, and pay-per-dose pricing.
12:00-1:15

Luncheon

Thomas Oxley, M.D., Ph.D., CEO and Founder, Synchron Inc.
 
1:15-2:00

Regulatory and Reimbursement Issues

Jeremy Koff, Senior Contributing Editor, Neurotech Reports, Moderator
Corey Hunter, M.D., Assistant Clinical Professor of Physical Medicine & Rehabilitation, Mount Sinai Hospital
Peter Staats, M.D., CMO, ElectroCore LLC
Victor Pikov, Ph.D., CEO, Medipace, Inc.
Startup and established bioelectronic medicine firms face a variety of regulatory and reimbursement issues on the way to commercialization. In this session, we'll explore key considerations in designing clinical trials, obtaining FDA approval, and getting reimbursement from payors.
2:00-3:00

Entrepreneur Panel II

James Cavuoto, Editor, Neurotech Reports, Moderator
David Hochman, Chairman and CEO, Orchestra Biomed
Nader Yaghoubi, M.D., Ph.D., CEO, PathMaker Neurosystems Inc.
Douglas Adams, CEO, Qura Inc.
Ana Maiques, CEO, Neuroelectrics Corp.
Presentations from executives of emerging bioelectronic medicine firms.
3:00-3:15

Refreshment Break

3:15-4:15

Translational Entrepreneur Panel

James Cavuoto, Editor, Neurotech Reports, Moderator
Jacob Zabara, Ph.D., President, Jacob Zabara Family Foundation
Gaurav Sharma, Ph.D., Technical Leader in Neuromodulation, Battelle
Shelley Fried, Ph.D., Associate Professor, Harvard Medical School, Mass General Hospital
Michael Jenkins, Ph.D., Investigator, Cleveland FES Center
Presentations from representatives of research institutions and nonprofit organizations seeking to commercialize new bioelectronic medicine therapies.
4:15-5:00

Future Outlook for Bioelectronic Medicine

James Cavuoto, Editor and Publisher, Neurotech Reports, Moderator
Kip Ludwig, Ph.D., Director, Bioelectronic Medicines Laboratory, University of Wisconsin
Elliot Krames, M.D., Former President, International Neuromodulation Society
Jeff Kramer, Ph.D., Vice-President, Research and Technology, Medtronic plc
In this closing session, we'll look at new applications for bioelectronic medicine, including potential therapies for treating immunological, dematalogical, and hematalogical disorders.
5:00-7:00

Cocktail Reception

 
 
      

©2019 Neurotech Reports. All rights reserved.